As of 30 Sep 2025, 1 institutional investors reported holding 25,984 shares of Novo Nordisk A/S - Common Stock - Foreign.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 25,984 | $1,408,511 | -$72,204 | $54.21 | 1 |
| 2025 Q2 | 27,316 | $1,895,893 | +$1,893,812 | $69.41 | 1 |
| 2025 Q1 | 30 | $2,043 | -$1,605,795 | $68.10 | 1 |
| 2024 Q4 | 18,560 | $1,608,692 | +$1,597,249 | $86.69 | 2 |
| 2024 Q3 | 132 | $15,509 | +$1,880 | $117.49 | 1 |
| 2024 Q2 | 116 | $16,751 | $0 | $144.41 | 1 |
| 2024 Q1 | 116 | $14,786 | +$14,786 | $127.47 | 1 |
| 2023 Q4 | 0 | $0 | -$39,768 | $54.21 | 0 |
| 2023 Q3 | 435 | $39,768 | +$39,768 | $91.42 | 1 |